豐德麗控股(00571.HK)年度淨虧損大幅收窄95.91%至3.51億港元
格隆匯10月19日丨豐德麗控股(00571.HK)公佈,截至2021年7月31日止年度,公司營業額為8.35億港元,同比下降10.10%;公司擁有人應占年內虧損為3.51億港元,同比收窄95.91%;基本每股虧損為0.235港元。
收入下降主要由於集團於回顧年度內來自電影及電視節目分部的收益減少所致。
虧損大幅收窄乃主要由於(i)2020年五月完成麗豐出售事項後不再錄得出售後的虧損及麗豐集團之經營業績;及(ii)於回顧年度內公司擁有人應占來自集團持續經營業務之淨虧損減少所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.